Cytodyn Inc

(CYDY)

By |

Profile

CytoDyn Inc is US-based clinical-stage biotechnology company which focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The lead product candidate is PRO 140, which is a class of HIV therapy called as entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes on exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.

Contact Information

Website: www.cytodyn.com
Email: info@cytodyn.com
Main Phone: +1 360 980-8524
Address: 1111 Main Street
Address 2: Suite 660
State: WA
City / Town: Vancouver
Country: USA
Postal Code: 98660

Issuer Information

Exchange: OTCQB
Employees: 6
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.51 $ -0.01 (-1.92%)
Last Price 0.51 Change $ -0.01 Change % -1.92 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.54 High 0.54 Low 0.51 Prev Close 0.52
Last Trade Volume 113,297 52 Wk Hi 0.84 52 Wk Low 0.40
Market Cap 130.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 256,382,949.00 EPS (TTM) -0.28 PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2 2 2 2
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 2 2 2 2
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/20/18 02/20/18 02/20/18 02/20/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1